These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 16705031)

  • 1. Another weapon against amyloid.
    Greenberg DA
    Proc Natl Acad Sci U S A; 2006 May; 103(21):7943-4. PubMed ID: 16705031
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores.
    Yang W; Wong Y; Ng OT; Bai LP; Kwong DW; Ke Y; Jiang ZH; Li HW; Yung KK; Wong MS
    Angew Chem Int Ed Engl; 2012 Feb; 51(8):1804-10. PubMed ID: 22086555
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicine. Prion-like behavior of amyloid-beta.
    Kim J; Holtzman DM
    Science; 2010 Nov; 330(6006):918-9. PubMed ID: 21071652
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems of the amyloid beta precursor protein in pathogenesis of the Alzheimer type dementia].
    Shoji M; Hirai S
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):164-8. PubMed ID: 8648890
    [No Abstract]   [Full Text] [Related]  

  • 5. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta/A4-type amyloid protein in Alzheimer's disease and cerebral amyloid angiopathies].
    Hirai S; Okamoto K
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1424-9. PubMed ID: 8245639
    [No Abstract]   [Full Text] [Related]  

  • 7. Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease.
    Dorr A; Sahota B; Chinta LV; Brown ME; Lai AY; Ma K; Hawkes CA; McLaurin J; Stefanovic B
    Brain; 2012 Oct; 135(Pt 10):3039-50. PubMed ID: 23065792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain.
    Kim HD; Kong FK; Cao Y; Lewis TL; Kim H; Tang DC; Fukuchi K
    Neurosci Lett; 2004 Nov; 370(2-3):218-23. PubMed ID: 15488326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.
    Selkoe DJ
    J Clin Invest; 2002 Nov; 110(10):1375-81. PubMed ID: 12438432
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model.
    Mouri A; Noda Y; Hara H; Mizoguchi H; Tabira T; Nabeshima T
    FASEB J; 2007 Jul; 21(9):2135-48. PubMed ID: 17341681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Repairing rhythms in the brain of Alzheimer's mouse models].
    Verret L
    Med Sci (Paris); 2012 Dec; 28(12):1044-7. PubMed ID: 23290398
    [No Abstract]   [Full Text] [Related]  

  • 12. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
    Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
    Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobiology. Untangling Alzheimer's by paring plaques bolsters amyloid theory.
    Beckman M
    Science; 2004 Aug; 305(5685):762. PubMed ID: 15297635
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.
    Caspersen C; Wang N; Yao J; Sosunov A; Chen X; Lustbader JW; Xu HW; Stern D; McKhann G; Yan SD
    FASEB J; 2005 Dec; 19(14):2040-1. PubMed ID: 16210396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding light on Alzheimer's β-amyloid aggregation with chemical tools.
    Kapurniotu A
    Chembiochem; 2012 Jan; 13(1):27-9. PubMed ID: 22113851
    [No Abstract]   [Full Text] [Related]  

  • 17. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development.
    Arendash GW
    J Alzheimers Dis; 2012; 32(2):243-66. PubMed ID: 22810103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
    Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
    Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphenylpropynone derivatives as probes for imaging β-amyloid plaques in Alzheimer's brains.
    Ono M; Watanabe H; Watanabe R; Haratake M; Nakayama M; Saji H
    Bioorg Med Chem Lett; 2011 Jan; 21(1):117-20. PubMed ID: 21145738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.